Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tri-Luma Atrophy Study in Melasma
NCT00469183Phase 4Completed
- Sponsor
- Galderma
- Start
- May 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tretinoin in melasma, sponsored by Galderma. Started May 2006; status: completed.
02
Drugs
tretinoin
03
Conditions
melasma
Beyond the preview
Go deeper on NCT00469183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469183.